The GH receptor antagonist pegvisomant is a highly effective new treatment option in acromegaly. The article describe indications, safety and efficacy of pegvisomant in clinical practice.
Pegvisomant in acromegaly: Why, when, how
DEGLI UBERTI, Ettore;
2007
Abstract
The GH receptor antagonist pegvisomant is a highly effective new treatment option in acromegaly. The article describe indications, safety and efficacy of pegvisomant in clinical practice.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
